Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost

PURPOSE: The preservative benzalkonium chloride (BAK) may adversely affect ocular surface health. This study evaluated symptoms of ocular surface disease (OSD) in patients previously treated with a BAK-preserved therapy to lower their intraocular pressure, who either continued that therapy or switch...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Katz, Gregory, Springs, Clark L, Craven, E Randy, Montecchi-Palmer, Michela
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2010
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2993125/
https://ncbi.nlm.nih.gov/pubmed/21151330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S14113
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky